Skip to content
FIND A HEALTH VALLEY ACTOR

Distalmotion raises $ 150M

Distalmotion

The fundraise, led by Revival Healthcare Capital, will be used to get a Food and Drug Administration (FDA) approval for Dexter, Distalmotion’s robotic surgery device.   Dexter, Distalmotion’s robotic platform, is already in day-to-day clinical use in Europe, successfully treating patients across a multitude of complex and high-volume procedures in general surgery, gynecology, urology. This…

Read More

Music practice keeps the brain from ageing

Senior Man and Music

A study led by the UNIGE, HES-SO Geneva, and EPFL revealed that music practice and active listening could prevent working memory decline.   About 130 retirees were separated into two groups. Each group took one type of music class for one hour per week for 12 months. These seniors, aged 62 to 78, also had…

Read More

Ludwig Cancer Research and Canton of Vaud Partner to Build a Research Centre

Biopôle - LICR

The new centre will be dedicated to synthetic immunotherapy and immune engineering on the Biopôle site in Epalinges.   The building covers more than 9,000 square meters; the future premises will be divided into two main areas, one dedicated to hosting research groups and the other to various platforms, including tools for cell imaging, cytometry…

Read More

Erwin Böttinger is the new Wyss Center Geneva CEO

Wyss Center CEO

The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, is pleased to announce the appointment of Prof. Dr. med. Erwin Böttinger as its new Chief Executive Officer (CEO).     Prof. Böttinger has a longstanding track record in personalized medicine, with emphasis on genomics and digital technologies. Before joining the…

Read More

Startup Days Bern

Startup Days

Startup Days takes place on 27 May 2027 in Kursaal Bern Startup Days (SUD) is a business and networking event for startups, investors, SMEs and corporates in Switzerland. Every year, the Swiss startup ecosystem meets to network and exchange know-how. At SUD, you are encouraged to think out of the box, grow your skills, and…

Read More

Lonza completed its latest drug manufacturing line in Visp

Ibex™ Lonza facilit in Visp Switzerland

The new line will support customers with a range of drug product manufacturing needs for both clinical and commercial supply.   Set in a 1,200 sqm cGMP facility, it includes a state-of-the-art liquid and lyophilized vial filling isolator line for multiple modalities that fulfils the GMP Annex 1 requirement for the manufacture of sterile products1.…

Read More

W.A. de Vigier Awards 2023: 7 Western Switzerland Life Sciences Startups Selected

De Vigier Awards

15 startups were selected among 300 projects. 5 of them are set to win CHF 100,000. The Award Ceremony is scheduled on 20 June 2023.   The Top 15 will now be further assessed through in-depth interviews with the foundation board as well as expert reports. The Top 10 are subsequently selected during two presentation…

Read More

An Obesity Center opens at the CHUV

Obesity Center CHUV

The creation of an Obesity Center at the CHUV enables the teams of Dr. Lucie Favre, head of the Obesity Consultation (Endocrinology Service), and Dr. Styliani Mantziari, head of the Bariatric Surgery Unit (Visceral Surgery Service), to combine their expertise in order to offer multidisciplinary and personalized care to patients who suffer from obesity.  …

Read More

Alithea Genomics receives CHF 500,000 from FIT

Alithea Genomics

The EPFL spin-off is active in high-throughput RNA sequencing, used to examine gene expression and discover new biomarkers and drugs. The Foundation for Technological Innovation (FIT) has chosen to give the company a Tech Growth loan of CHF 500,000.     Since the Covide-19 pandemic, RNA sequencing is widely used in for fundamental research studies,…

Read More

Lunaphore raises CHF 40 million in Series D1 funding

Lunaphore

The Swiss startup plans to use the funding to strengthen its growing portfolio offering in spatial biology.     Lunaphore Technologies S.A is a Vaud-based spatial biology company, building multiplex immunofluorescence & IHC solutions for discovery and immuno-oncology research. The startup announced that it has completed CHF 40M in Series D1 funding. The round was…

Read More